Therapy by Phone or Web Improves Patient-Reported Outcomes in IBS Therapy by Phone or Web Improves Patient-Reported Outcomes in IBS
Cognitive behavioral therapy (CBT) delivered by phone or online leads to improvements in patient-reported outcomes in irritable bowel syndrome (IBS), according to a clinical trial from the U.K.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 24, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news
Stomach bloating: Five things that could be triggering IBS
STOMACH bloating is often caused by eating certain food or drink or eating too much, but in some cases, it can be the sign of a condition known as irritable bowel syndrome . There are a number of unexpected things which could be triggering this gut condition. (Source: Daily Express - Health)
Source: Daily Express - Health - April 24, 2019 Category: Consumer Health News Source Type: news
Cognitive Behavioral Therapy Aids Irritable Bowel Symptoms
Improvements in symptoms, life impact maintained at 12 months (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - April 23, 2019 Category: Psychiatry Tags: Gastroenterology, Psychiatry, Journal, Source Type: news
Cognitive Behavioral Therapy Aids Irritable Bowel Symptoms
TUESDAY, April 23, 2019 -- Both telephone-delivered and web-delivered cognitive behavioral therapy (CBT) can significantly improve irritable bowel syndrome (IBS) symptoms, according to a study published online April 10 in Gut.
Hazel Anne Everitt,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 23, 2019 Category: Pharmaceuticals Source Type: news
The Overlap of IBS and Nonceliac Gluten Sensitivity The Overlap of IBS and Nonceliac Gluten Sensitivity
This review explores possible etiologies for nonceliac gluten sensitivity, as well as the complex relationship between NCGS and irritable bowel syndrome.Current Opinion in Gastroenterology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 22, 2019 Category: Allergy & Immunology Tags: Gastroenterology Journal Article Source Type: news
Microbial Features ID'd for Pediatric Irritable Bowel Syndrome
WEDNESDAY, April 17, 2019 -- Microbial and metabolic features can distinguish children with irritable bowel syndrome (IBS) from controls, according to a study published online April 17 in the Journal of Molecular Diagnostics.
Emily B. Hollister,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2019 Category: Pharmaceuticals Source Type: news
Microbiome science may help doctors deliver more effective, personalized treatment to children with irritable bowel syndrome
(Elsevier) To improve the treatment of children with irritable bowel syndrome (IBS), investigators have developed a sophisticated way to analyze the microbial and metabolic contents of the gut. A report in The Journal of Molecular Diagnostics, published by Elsevier, describes how a new battery of tests enables researchers to distinguish patients with IBS from healthy children and identifies correlations between certain microbes and metabolites with abdominal pain. With this information, doctors envision tailoring nutritional and targeted therapies that address a child's specific gastrointestinal problems. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 17, 2019 Category: Biology Source Type: news
Gut-health expert reveals his 18 best tips to tackle irritable bowel syndrome
IBS is unpleasant to say the least and affects nearly half of us. But Dr Simon Smale, a consultant gastroenterologist at Manchester University, says we needn't suffer in silence. (Source: the Mail online | Health)
Source: the Mail online | Health - April 16, 2019 Category: Consumer Health News Source Type: news
Yoga 'eases my Irritable Bowel Syndrome'
Sufferers of Irritable Bowel Syndrome describe how tailored yoga classes are helping their condition. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 12, 2019 Category: Consumer Health News Source Type: news
Medical News Today: IBS: Telephone- and web-based CBT relieve symptoms
A trial finds that both web- and telephone-based cognitive behavioral therapy relieve symptoms of irritable bowel syndrome better than standard care alone. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 12, 2019 Category: Consumer Health News Tags: Irritable Bowel Syndrome Source Type: news
Web therapy 'calmed my irritable bowels'
People with irritable bowel syndrome could have fewer symptoms after web-based therapy, research suggests. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 11, 2019 Category: Consumer Health News Source Type: news
CBT can provide ‘better’ relief for irritable bowel symptoms
Cognitive behavioural therapy tailored specifically for irritable bowel syndrome (IBS) is more effective in relieving the symptoms than usual care, according to UK researchers. (Source: Nursing Times)
Source: Nursing Times - April 11, 2019 Category: Nursing Source Type: news
Talking therapy could cure IBS better than drugs, study reveals
A study of more than 500 patients by the University of Southampton found that counselling over the phone or online greatly reduced painful symptoms associated with irritable bowel syndrome. (Source: the Mail online | Health)
Source: the Mail online | Health - April 10, 2019 Category: Consumer Health News Source Type: news
Stomach bloating: Four signs your bloated stomach pain is a symptom of IBS
STOMACH bloating commonly happens after eating food which is hard to digest, but in some cases it can be a sign of an underlying condition like irritable bowel syndrome. But how do you know if your bloated stomach pain is IBS? Here are four signs. (Source: Daily Express - Health)
Source: Daily Express - Health - April 10, 2019 Category: Consumer Health News Source Type: news
US WorldMeds gets FDA greenlight for drug previously pulled for safety concerns
US WorldMeds LLC received final approval to reintroduce an irritable bowel syndrome drug that was pulled from the market in 2007 because of patient safety concerns.
The Louisville special specialty pharmaceutical company said the Food and Drug Administration had given it final approval to market tegaserod, which is branded as Zelnorm, for the treatment of irritable bowel syndrome with constipation, or IBS-C, in women under 65.
The approval was received thro ugh Sloan Pharma, S.a.r.l., a subsidiary… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 8, 2019 Category: Biotechnology Authors: Chris Larson Source Type: news
